Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between C-reactive protein and risk of schizophrenia: An updated meta-analysis
Zhichao Wang, Ping Li, Dianyuan Chi, et al.
Oncotarget (2017) Vol. 8, Iss. 43, pp. 75445-75454
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives
Evgeny A. Ermakov, Mark M. Melamud, Valentina N. Buneva, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 96
Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway
Alexandre Vallée
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2810-2810
Open Access | Times Cited: 88
C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review
Guillaume Fond, Christophe Lançon, Pascal Auquier, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 76
Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics
Rune A. Kroken, Iris E. Sommer, Vidar M. Steen, et al.
Frontiers in Psychiatry (2019) Vol. 9
Open Access | Times Cited: 76
Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis
Valentine Lestra, Bruno Roméo, Catherine Martelli, et al.
Schizophrenia Research (2022) Vol. 246, pp. 175-186
Open Access | Times Cited: 31
Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis
Maria Antonietta Nettis, Giulio Pergola, Anna Kolliakou, et al.
Psychoneuroendocrinology (2018) Vol. 99, pp. 145-153
Open Access | Times Cited: 48
The Effects of Probiotic and Selenium Co-supplementation on Clinical and Metabolic Scales in Chronic Schizophrenia: a Randomized, Double-blind, Placebo-Controlled Trial
Hamidreza Jamilian, Amir Ghaderi
Biological Trace Element Research (2021) Vol. 199, Iss. 12, pp. 4430-4438
Closed Access | Times Cited: 34
Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets
Matej Ľupták, Danica Michaličková, Zdeněk Fišar, et al.
World Journal of Psychiatry (2021) Vol. 11, Iss. 7, pp. 277-296
Open Access | Times Cited: 30
Blood-based kynurenine pathway alterations in schizophrenia spectrum disorders: A meta-analysis
Manuel Morrens, Livia De Picker, Jarl K. Kampen, et al.
Schizophrenia Research (2020) Vol. 223, pp. 43-52
Closed Access | Times Cited: 29
Role and Perspectives of Inflammation and C-Reactive Protein (CRP) in Psychosis: An Economic and Widespread Tool for Assessing the Disease
Irfan Ullah, Hashir Ali Awan, Alifiya Aamir, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13032-13032
Open Access | Times Cited: 24
hsa_circRNA_104597: a novel potential diagnostic and therapeutic biomarker for schizophrenia
Gaofeng Yao, Wei Niu, Xiaoli Zhu, et al.
Biomarkers in Medicine (2019) Vol. 13, Iss. 5, pp. 331-340
Open Access | Times Cited: 29
Serum inflammatory markers and their associations with white matter integrity of the corpus callosum in schizophrenia patients and healthy controls
Anna Michalczyk, Ernest Tyburski, Piotr Podwalski, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 116, pp. 110510-110510
Closed Access | Times Cited: 16
The effect of clozapine on immune-related biomarkers in schizophrenia patients
Lu Shao, Li Yu, ZhiYao Yuan, et al.
Brain Research Bulletin (2024), pp. 111104-111104
Open Access | Times Cited: 3
Low-grade inflammation in first-episode psychosis is determined by increased waist circumference
Jaakko Keinänen, Jaana Suvisaari, Jaakko Reinikainen, et al.
Psychiatry Research (2018) Vol. 270, pp. 547-553
Closed Access | Times Cited: 18
Serum Inflammatory Markers and Their Associations with the Integrity of the Cingulum Bundle in Schizophrenia, from Prodromal Stages to Chronic Psychosis
Anna Michalczyk, Ernest Tyburski, Piotr Podwalski, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6352-6352
Open Access | Times Cited: 8
Galectin-1 and Galectin-3 Levels in Patients with Schizophrenia and their Unaffected Siblings
Rabia Nazik Yüksel, Diğdem Göverti, Aybeniz Civan Kahve, et al.
Psychiatric Quarterly (2020) Vol. 91, Iss. 3, pp. 715-725
Closed Access | Times Cited: 11
Associations of C-Reactive Protein, Free Triiodothyronine, Thyroid Stimulating Hormone and Creatinine Levels with Agitation in Patients with Schizophrenia: A Comparative Cross-Sectional Study
Chao Li, Zhenchun Shi, Jiacui Ji, et al.
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 2575-2585
Open Access | Times Cited: 10
Elevated C-reactive protein as a predictor of a random one-year clinical course in the first ten years of schizophrenia
Leticia González-Blanco, María Paz García‐Portilla, Leticia García-Álvarez, et al.
Psychiatry Research (2018) Vol. 269, pp. 688-691
Closed Access | Times Cited: 9
C-reactive protein as a potential biomarker in psychiatric practice: Are we there yet?
Erensu Baysak, Demet Sinem Güden, Feyza Arıcıoğlu, et al.
The World Journal of Biological Psychiatry (2021) Vol. 23, Iss. 4, pp. 243-256
Closed Access | Times Cited: 8
Recent advancements in biomarker research in schizophrenia: mapping the road from bench to bedside
Shivangi Patel, Dilip Kumar Sharma, Ankit Uniyal, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 7, pp. 2197-2211
Closed Access | Times Cited: 6
Effect of the C-reactive protein gene on risk and clinical characteristics of schizophrenia in winter-born individuals
М. В. Алфимова, Tatyana Lezheiko, Svetlana V. Smirnova, et al.
European Neuropsychopharmacology (2020) Vol. 35, pp. 81-88
Closed Access | Times Cited: 8
Lower fractional anisotropy without evidence for neuro-inflammation in patients with early-phase schizophrenia spectrum disorders
Shiral S. Gangadin, René C.W. Mandl, Lot D. de Witte, et al.
Schizophrenia Research (2022) Vol. 264, pp. 557-566
Open Access | Times Cited: 5
The interaction between positive schizotypy and high sensitivity C-reactive protein on response inhibition in female individuals
Jingbo Gong, Ya Wang, Jianbo Liu, et al.
Psychiatry Research (2019) Vol. 274, pp. 365-371
Closed Access | Times Cited: 5
Association of high-sensitivity C-reactive protein with susceptibility to Schizophrenia in Tunisian population
Fairouz Ayari, Arij Ben Chaaben, H. Ben Ammar, et al.
L Encéphale (2020) Vol. 46, Iss. 4, pp. 241-247
Closed Access | Times Cited: 5
In the afterglow: Immune dysfunction in schizophrenia spectrum disorders
Shiral S. Gangadin
(2024)
Open Access
Page 1 - Next Page

Scroll to top